BI
STLNW

Bulldog Investors’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Bulldog Investors’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75,267
Closed -$52K – 341
2021
Q4 		$52K Sell
75,267
-1,555
-2% -$1.92K 0.01% 231
2021
Q3 		$94K Hold
76,822
– – 0.03% 198
2021
Q2 		$133K Hold
76,822
– – 0.04% 193
2021
Q1 		$104K Hold
76,822
– – 0.03% 179
2020
Q4 		$150K Buy
+76,822
New +$132K 0.06% 126

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bulldog Investors's STLNW Position: Q1 2022 in Review

Bulldog Investors sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2022, closing a stake of 75,267 shares — an estimated $52K sold.

Bulldog Investors first reported a position in STLNW in Q4 2020 and held it in 5 quarters. The position peaked at $150K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q1 2022.

  • Bulldog Investors reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Bulldog Investors sold 75,267 Starling Oncology, Inc. Warrant shares in Q1 2022, an estimated $52K.
  • Bulldog Investors first reported a position in Starling Oncology, Inc. Warrant in Q4 2020 and held it in 5 quarters.
  • Bulldog Investors's Starling Oncology, Inc. Warrant position peaked at $150K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2022.

Based on Bulldog Investors's 13F filing for Q1 2022, filed 13 May 2022.